$ENVA

Fisher David sold $6.6M of ENVA

Fisher David (Executive Chairman) sold 28,500 shares of Enova International, Inc. (ENVA) at an average of $231.49 ($231.45–$231.51, $6.60M total) across 2 trades over 2026-07-14 to 2026-07-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fisher David
Published Jul 16, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 16, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

The disclosure updates the insider’s post-sale holdings and confirms the sale was executed via an open-market transaction under a pre-arranged 10b5-1 plan.

02

Market read

This is a routine insider-sale filing with limited incremental fundamental information due to the 10b5-1 plan.

03

What to watch

Traders may overreact to insider sales; the key differentiator here is the explicitly stated pre-arranged 10b5-1 plan, which often reduces informational content.

Relevance 5/10Novelty 4/10Timing: SEC Form 4 filed 2026-07-16 after-hours.

Background

The article is an SEC Form 4 insider transaction disclosure for Enova International, Inc.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova executive chairman David Fisher sold 28,500 shares in open-market trades for about $6.6M under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any reaction should be muted given the 10b5-1 structure.

Evidence & confidence

The filing provides exact trade dates, share count, and value, but the presence of a pre-arranged 10b5-1 plan typically lowers interpretive weight for fundamentals.

Market effects

Minimal, as this is a single-company insider transaction without sector-wide disclosures.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect routine liquidity needs rather than a bearish view on Enova’s prospects.

Key entities

  • Enova International, Inc.

    Company whose executive chairman reported open-market share sales on Form 4.

  • Fisher David

    Executive Chairman and officer/director who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMed

Citizens raises Enova stock price target on strong growth outlook

Citizens raised its price target for Enova International (NYSE:ENVA) to $220 from $215, citing strong growth and stable credit quality. The company reported 30%+ originations growth and 30%+ EPS growth for multiple quarters. Enova's stock has gained 55% over the past year, but may be overvalued according to InvestingPro's Fair Value analysis. Citizens also increased its 2027 adjusted EPS estimate to $22.03 from $21.47, expecting more aggressive share buybacks.

$ENVAMedAI 8/10

Enova International Inc (ENVA) Q3 2026 Earnings Call Highlights: Revenue Tops $1 Billion

Enova International Inc (ENVA) reported Q3 2026 revenue exceeding $1 billion, up 26% YoY, with adjusted EPS increasing 33% to $4.48. Originations grew 31% YoY to $2.6 billion, marking 12 consecutive quarters of at least 20% growth. The company noted increased marketing expenses and SMB delinquencies, while withdrawing bank applications. Management expects Q4 2026 revenue to rise 25% YoY with stable margins.

$ENVAMedAI 8/10

Enova Tops $1 Billion Quarterly Revenue as Online Lending

Enova reported Q3 2026 revenue of $1.1 billion, up 26% YoY, with originations and adjusted EPS also rising significantly. Net charge-off ratio improved to 8.1%. The company's portfolio reached $5.9 billion, with small business products comprising 68%. Enova withdrew its bank regulatory applications for Grasshopper Bancorp acquisition, citing regulatory misalignment, but expects continued growth.

$ENVAMed

What Enova International (ENVA) Said on Its Q3 Earnings Call

Enova International (ENVA) reported Q3 improvements in net charge-off ratios and revenue margins, with consolidated net revenue margin at 61%. The company expects Q4 margins between 55% and 60%. Marketing expenses rose to 23% of revenue, supporting growth. Enova has $1.3B in liquidity and repurchased 243,000 shares. It forecasts 25% revenue growth and 30-35% adjusted EPS increase for Q4. The company is exploring new product opportunities in consumer and small-business lending.

$ENVAMedAI 8/10

Enova (ENVA) Q3 2026 Earnings Call Transcript

Enova (ENVA) reported Q3 2026 earnings with 26% revenue growth to over $1 billion, driven by 30% portfolio growth. Consumer and small business originations increased 37% and 28% respectively. Adjusted EPS rose 33%. Net charge-off rates improved, with the consolidated rate at 8.1%. The company expects strong Q4 results, citing resilient macroeconomic conditions and consumer spending.